<DOC>
	<DOCNO>NCT00969813</DOCNO>
	<brief_summary>This study design evaluate CP-690,550 handle body healthy volunteer mild moderate hepatic impairment compare healthy volunteer normal hepatic function . This study also evaluate safety tolerability CP-690,550 .</brief_summary>
	<brief_title>A Safety Tolerability Study CP-690,550 Subjects With Hepatic Impairment Normal Hepatic Function</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Healthy volunteer normal liver function , subject either mild moderate liver impairment . Subjects severe liver impairment Subjects weaken immune system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Hepatic impairment</keyword>
</DOC>